Bristol-Myers
Squibb Company (NYSE:BMY) will announce results for the second
quarter of 2018 on Thursday, July 26, 2018. During a conference call at
10:30 a.m. EDT on July 26, company executives will review financial
information and will address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast
of the call at http://investor.bms.com
or by dialing in the U.S. toll free 323-794-2093 or international
866-548-4713, confirmation code: 4235170. Materials related to the call
will be available at the same website prior to the conference call. A
replay of the call will be available beginning at 1:30 p.m. EDT on July
26 through 1:30 p.m. EDT on, August 9, 2018. The replay will also be
available through http://investor.bms.com
or by dialing in the U.S. toll free 888-203-1112 or international
719-457-0820, confirmation code: 4235170.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,
Twitter,
and YouTube.
Bristol-Myers Squibb Company Media: Ken Dominski, 609-252-5251 ken.dominski@bms.com orLisa McCormick Lavery, 609-252-7602 lisa.mccormicklavery@bms.com or Investors: John Elicker, 609-252-4611 john.elicker@bms.com orTim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com